Dear Reader,
Mesothelioma is a rare but aggressive cancer that affects the lining of the lungs, abdomen, and heart. It is caused by exposure to asbestos, a naturally occurring mineral that was widely used in construction, shipbuilding, and other industries throughout the 20th century. Despite the ban on asbestos in many countries, mesothelioma remains a global health issue, and its incidence is expected to increase in the coming years.
At Brigham and Women’s Hospital, we are committed to providing world-class care and cutting-edge research for mesothelioma patients. Our International Mesothelioma Program brings together a multidisciplinary team of experts in oncology, surgery, pathology, radiology, and nursing, who work collaboratively to diagnose, treat, and support patients and their families throughout their journey.
What is the Brigham and Women’s Hospital International Mesothelioma Program?
The Brigham and Women’s Hospital International Mesothelioma Program (IMP) is a specialized center that focuses on mesothelioma treatment, research, education, and advocacy. It was founded in 2002 by Dr. David Sugarbaker, a renowned thoracic surgeon and mesothelioma expert, who pioneered many of the current surgical techniques and protocols used in the field.
The IMP provides comprehensive and personalized care for patients with mesothelioma and related diseases, including lung cancer, asbestosis, and pleural effusion. Our team uses a multidisciplinary approach, which means that each patient is evaluated by several specialists who work together to create a customized treatment plan that takes into account their unique medical history, stage of cancer, and overall health.
In addition to clinical care, the IMP is also involved in leading-edge research that aims to improve the understanding, prevention, and treatment of mesothelioma. Our researchers collaborate with other institutions and organizations around the world to develop new therapies, biomarkers, and diagnostic tools that can help diagnose and treat mesothelioma earlier and more effectively.
The IMP also provides education and training for healthcare professionals, patients, and families about mesothelioma and related topics. We organize conferences, symposiums, webinars, and other events that bring together experts and stakeholders from different fields to exchange ideas and best practices. We also offer support groups, counseling, and other resources for patients and their families to help them cope with the physical, emotional, and financial challenges of mesothelioma.
How Does the Brigham and Women’s Hospital International Mesothelioma Program Work?
The IMP’s approach to mesothelioma care and research is based on four core principles: collaboration, innovation, compassion, and excellence.
Collaboration
The IMP takes a team-based approach to mesothelioma care and research, which means that patients benefit from the expertise of multiple specialists who work together to provide integrated and seamless care. Our team includes:
| Specialty | Expertise |
|---|---|
| Thoracic Surgery | Minimally invasive surgery, radical surgery, extrapleural pneumonectomy, pleurectomy/decortication, VATS, robotic surgery, HIPEC |
| Medical Oncology | Systemic chemotherapy, targeted therapy, immunotherapy, clinical trials, supportive care |
| Radiation Oncology | External beam radiation, brachytherapy, SBRT, proton therapy |
| Radiology | Chest CT, PET-CT, MRI, ultrasound, biopsy, imaging-guided interventions |
| Pathology | Diagnostic biopsy, molecular profiling, biomarker testing, tissue banking |
| Nursing | Patient education, symptom management, care coordination, survivorship |
Our team meets regularly to discuss each patient’s case and to coordinate their care. We use the latest diagnostic and treatment technologies, such as robotic surgery, immunotherapy, and proton therapy, to provide patients with the best possible outcomes.
Innovation
The IMP is committed to advancing the field of mesothelioma care and research through innovation. We are involved in many clinical trials and research studies that explore new treatments, biomarkers, and diagnostic tools that can improve diagnosis, treatment, and prognosis for mesothelioma patients. Our team includes several world-renowned researchers and scholars who have published numerous articles and papers that have contributed to the current understanding of mesothelioma.
Compassion
At the IMP, we understand that mesothelioma can have a significant impact on patients and their families. We strive to provide compassionate and patient-centered care that addresses their physical, emotional, and spiritual needs. We also offer support groups, counseling, and other resources that help patients and their families cope with the challenges of mesothelioma.
Excellence
The IMP is recognized as a leader in mesothelioma care and research, both nationally and internationally. We have a track record of excellence in providing the highest quality care and conducting groundbreaking research that advances the field. Our team includes several award-winning clinicians and researchers who have received recognition for their contributions to mesothelioma care and research.
FAQs about the Brigham and Women’s Hospital International Mesothelioma Program
1. What are the symptoms of mesothelioma?
The symptoms of mesothelioma are often vague and similar to those of other respiratory diseases, such as cough, shortness of breath, chest pain, fatigue, and weight loss. These symptoms may not appear until several decades after exposure to asbestos, which makes early diagnosis challenging.
2. How is mesothelioma diagnosed?
Mesothelioma is typically diagnosed through a combination of imaging tests, such as chest CT and MRI, and biopsy, which involves the removal of a small tissue sample for examination under a microscope. Additional tests, such as biomarker testing and molecular profiling, may also be performed to inform treatment decisions.
3. What are the treatment options for mesothelioma?
The treatment options for mesothelioma depend on several factors, including the stage of cancer, the location of the tumor, and the patient’s overall health. The main treatment modalities include surgery, chemotherapy, and radiation therapy, and these may be used alone or in combination. Other treatments, such as immunotherapy and targeted therapy, may also be available through clinical trials.
4. What is the prognosis for mesothelioma?
The prognosis for mesothelioma varies depending on several factors, such as the stage of cancer, the age and overall health of the patient, and the treatment approach. Mesothelioma is typically associated with poor prognosis, but early diagnosis and aggressive treatment can improve survival rates and quality of life.
5. What is the role of research in the Brigham and Women’s Hospital International Mesothelioma Program?
The IMP is involved in leading-edge research that aims to improve the understanding, prevention, and treatment of mesothelioma. Our researchers collaborate with other institutions and organizations around the world to develop new therapies, biomarkers, and diagnostic tools that can help diagnose and treat mesothelioma earlier and more effectively.
6. How can patients and families access the services of the Brigham and Women’s Hospital International Mesothelioma Program?
Patients and families can access the services of the IMP through a referral from their healthcare provider or by contacting our program directly. Our team will work with each patient and family to evaluate their needs, provide information about our services, and coordinate their care.
7. What sets the Brigham and Women’s Hospital International Mesothelioma Program apart from other mesothelioma centers?
The IMP is recognized as a leader in mesothelioma care and research, both nationally and internationally. Our team brings together experts from multiple specialties who work together to provide personalized and comprehensive care for each patient. We also conduct cutting-edge research that advances the field and improves the understanding, prevention, and treatment of mesothelioma.
8. Can mesothelioma be prevented?
Mesothelioma can be prevented by avoiding exposure to asbestos, which is the primary cause of the disease. However, because asbestos was widely used in many industries throughout the 20th century, many people have already been exposed and may develop mesothelioma later in life. It is important to be aware of the risks of asbestos exposure and to take precautions when working or living in environments where asbestos may be present.
9. What is the role of surgery in the treatment of mesothelioma?
Surgery plays a critical role in the treatment of mesothelioma, particularly in early-stage or localized disease. Surgical options may include minimally invasive surgery, radical surgery, extrapleural pneumonectomy, pleurectomy/decortication, VATS, robotic surgery, and HIPEC. The choice of surgery depends on several factors, such as the location and size of the tumor, the stage of cancer, and the patient’s overall health.
10. What is the role of chemotherapy in the treatment of mesothelioma?
Chemotherapy is a common treatment for mesothelioma, particularly in advanced or metastatic disease. Chemotherapy uses drugs that kill cancer cells or prevent them from growing and dividing. Chemotherapy may be used alone or in combination with other treatments, such as surgery and radiation therapy.
11. What is the role of radiation therapy in the treatment of mesothelioma?
Radiation therapy uses high-energy radiation to kill cancer cells or prevent them from growing and dividing. Radiation therapy may be used alone or in combination with other treatments, such as surgery and chemotherapy. Radiation therapy may also be used to relieve symptoms, such as pain and shortness of breath, in advanced or metastatic disease.
12. Who is at risk for mesothelioma?
Individuals who have been exposed to asbestos are at risk for developing mesothelioma. Risk factors for asbestos exposure include working in industries such as construction, shipbuilding, and manufacturing, as well as living in or near buildings that contain asbestos materials. It is important to be aware of the risks of asbestos exposure and to take precautions when working or living in environments where asbestos may be present.
13. How can I learn more about mesothelioma and the Brigham and Women’s Hospital International Mesothelioma Program?
You can learn more about mesothelioma and the IMP by visiting our website or by contacting our program directly. We offer a range of resources, such as patient education materials, support groups, and newsletters, that can provide you with the information and support you need. You can also sign up for our mailing list or attend one of our events to stay up-to-date on the latest developments in mesothelioma care and research.
Conclusion: Fighting for a Mesothelioma-Free Future
At the Brigham and Women’s Hospital International Mesothelioma Program, we are committed to fighting mesothelioma and to improving the lives of patients and their families. Our team of experts uses a collaborative and innovative approach to provide personalized and compassionate care for each patient, while also conducting leading-edge research that has the potential to transform the field.
But we cannot do this alone. We need the support of our community, our partners, and our donors to continue our mission and to achieve a mesothelioma-free future. We invite you to join us in this fight and to make a difference in the lives of those affected by mesothelioma.
Closing: Important Information and Disclaimer
The information provided in this article is for educational and informational purposes only and should not be construed as medical advice or as a substitute for professional medical care. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have about a medical condition or treatment.
The Brigham and Women’s Hospital International Mesothelioma Program is not responsible for the accuracy, completeness, suitability, or validity of any information contained in this article or in any other resources provided by our program. We make no warranties or representations of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability with respect to the information contained in this article or in any other resources provided by our program.
The use of any information provided in this article is solely at your own risk. In no event shall the Brigham and Women’s Hospital International Mesothelioma Program be liable for any injury, loss, claim, or damages of any kind arising from or in connection with the use of this article or any other resources provided by our program.
